Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study

<p>Abstract</p> <p>Background</p> <p>Human papillomaviruses are the most common sexually transmitted infections, and genital warts, caused by HPV-6 and 11, entail considerable morbidity and cost. The natural history of genital warts in relation to HIV-1 infection has no...

Полное описание

Библиографические подробности
Главные авторы: Van de Perre Philippe, Segondy Michel, Ouedraogo Abdoulaye, Huet Charlotte, Didelot-Rousseau Marie-Noelle, Nagot Nicolas, Konate Issouf, Clayton Tim, Low Andrea J, Mayaud Philippe
Формат: Статья
Язык:English
Опубликовано: BMC 2011-01-01
Серии:BMC Infectious Diseases
Online-ссылка:http://www.biomedcentral.com/1471-2334/11/20
_version_ 1828772448873480192
author Van de Perre Philippe
Segondy Michel
Ouedraogo Abdoulaye
Huet Charlotte
Didelot-Rousseau Marie-Noelle
Nagot Nicolas
Konate Issouf
Clayton Tim
Low Andrea J
Mayaud Philippe
author_facet Van de Perre Philippe
Segondy Michel
Ouedraogo Abdoulaye
Huet Charlotte
Didelot-Rousseau Marie-Noelle
Nagot Nicolas
Konate Issouf
Clayton Tim
Low Andrea J
Mayaud Philippe
author_sort Van de Perre Philippe
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Human papillomaviruses are the most common sexually transmitted infections, and genital warts, caused by HPV-6 and 11, entail considerable morbidity and cost. The natural history of genital warts in relation to HIV-1 infection has not been described in African women. We examined risk factors for genital warts in a cohort of high-risk women in Burkina Faso, in order to further describe their epidemiology.</p> <p>Methods</p> <p>A prospective study of 765 high-risk women who were followed at 4-monthly intervals for 27 months in Burkina Faso. Logistic and Cox regression were used to identify factors associated with prevalent, incident and persistent genital warts, including HIV-1 serostatus, CD4+ count, and concurrent sexually transmitted infections. In a subset of 306 women, cervical HPV DNA was tested at enrolment.</p> <p>Results</p> <p>Genital wart prevalence at baseline was 1.6% (8/492) among HIV-uninfected and 7.0% (19/273) among HIV-1 seropositive women. Forty women (5.2%) experienced at least one incident GW episode. Incidence was 1.1 per 100 person-years among HIV-uninfected women, 7.4 per 100 person-years among HIV-1 seropositive women with a nadir CD4+ count >200 cells/μL and 14.6 per 100 person-years among HIV-1 seropositive women with a nadir CD4+ count ≤200 cells/μL. Incident genital warts were also associated with concurrent bacterial vaginosis, and genital ulceration. Antiretroviral therapy was not protective against incident or persistent genital warts. Detection of HPV-6 DNA and abnormal cervical cytology were strongly associated with incident genital warts.</p> <p>Conclusions</p> <p>Genital warts occur much more frequently among HIV-1 infected women in Africa, particularly among those with low CD4+ counts. Antiretroviral therapy did not reduce the incidence or persistence of genital warts in this population.</p>
first_indexed 2024-12-11T14:44:03Z
format Article
id doaj.art-b83fa9d4b7af4c5a85eab34cd84f5de1
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-11T14:44:03Z
publishDate 2011-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-b83fa9d4b7af4c5a85eab34cd84f5de12022-12-22T01:01:46ZengBMCBMC Infectious Diseases1471-23342011-01-011112010.1186/1471-2334-11-20Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal studyVan de Perre PhilippeSegondy MichelOuedraogo AbdoulayeHuet CharlotteDidelot-Rousseau Marie-NoelleNagot NicolasKonate IssoufClayton TimLow Andrea JMayaud Philippe<p>Abstract</p> <p>Background</p> <p>Human papillomaviruses are the most common sexually transmitted infections, and genital warts, caused by HPV-6 and 11, entail considerable morbidity and cost. The natural history of genital warts in relation to HIV-1 infection has not been described in African women. We examined risk factors for genital warts in a cohort of high-risk women in Burkina Faso, in order to further describe their epidemiology.</p> <p>Methods</p> <p>A prospective study of 765 high-risk women who were followed at 4-monthly intervals for 27 months in Burkina Faso. Logistic and Cox regression were used to identify factors associated with prevalent, incident and persistent genital warts, including HIV-1 serostatus, CD4+ count, and concurrent sexually transmitted infections. In a subset of 306 women, cervical HPV DNA was tested at enrolment.</p> <p>Results</p> <p>Genital wart prevalence at baseline was 1.6% (8/492) among HIV-uninfected and 7.0% (19/273) among HIV-1 seropositive women. Forty women (5.2%) experienced at least one incident GW episode. Incidence was 1.1 per 100 person-years among HIV-uninfected women, 7.4 per 100 person-years among HIV-1 seropositive women with a nadir CD4+ count >200 cells/μL and 14.6 per 100 person-years among HIV-1 seropositive women with a nadir CD4+ count ≤200 cells/μL. Incident genital warts were also associated with concurrent bacterial vaginosis, and genital ulceration. Antiretroviral therapy was not protective against incident or persistent genital warts. Detection of HPV-6 DNA and abnormal cervical cytology were strongly associated with incident genital warts.</p> <p>Conclusions</p> <p>Genital warts occur much more frequently among HIV-1 infected women in Africa, particularly among those with low CD4+ counts. Antiretroviral therapy did not reduce the incidence or persistence of genital warts in this population.</p>http://www.biomedcentral.com/1471-2334/11/20
spellingShingle Van de Perre Philippe
Segondy Michel
Ouedraogo Abdoulaye
Huet Charlotte
Didelot-Rousseau Marie-Noelle
Nagot Nicolas
Konate Issouf
Clayton Tim
Low Andrea J
Mayaud Philippe
Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study
BMC Infectious Diseases
title Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study
title_full Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study
title_fullStr Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study
title_full_unstemmed Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study
title_short Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study
title_sort genital warts and infection with human immunodeficiency virus in high risk women in burkina faso a longitudinal study
url http://www.biomedcentral.com/1471-2334/11/20
work_keys_str_mv AT vandeperrephilippe genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT segondymichel genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT ouedraogoabdoulaye genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT huetcharlotte genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT didelotrousseaumarienoelle genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT nagotnicolas genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT konateissouf genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT claytontim genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT lowandreaj genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy
AT mayaudphilippe genitalwartsandinfectionwithhumanimmunodeficiencyvirusinhighriskwomeninburkinafasoalongitudinalstudy